Heat Biologics Stock News

The stock price of Heat Biologics Inc (NASDAQ:HTBX) increased by over 103.1% in its day high. This is why it happened.

Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" interim data from a Phas

Heat Biologics Inc (NASDAQ: HTBX) soars in premarket on the heels of encouraging interim data from the Phase 2 trial evaluating HS-110, in combination with Bristol-Myers Squibb's (NYSE: BMY) Opd

The stock price of Heat Biologics Inc (NASDAQ: HTBX) has increased by over 6%. This is why it happened.

Heat Biologics: Investors Would Be Wise To Hold Off Until 2H 2021 Clinical Trial Interim Results

DURHAM, NC / ACCESSWIRE / January 19, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immu

DURHAM, NC / ACCESSWIRE / January 11, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the im

DURHAM, NC / ACCESSWIRE / January 8, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immun

Heat Biologics (HTBX) has announced details for a reverse stock split in order to keep shares of HTBX stock trading on the Nasdaq. The post Heat Biologics Reverse Stock Split: 10 Things for HTBX Stock

Heat Biologics boosts patents portfolio with gp96 combination award. Teleflex announces acquisition of hemostatic company Z-Medica.

Foundation Medicine, Inc. and Takeda Pharmaceuticals USA, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK)

Les compagnies pharmaceutiques Janssen de Johnson & Johnson ont annoncé aujourd'hui que plusieurs présentations de données de leur portefeuille et

The huge amount of Operation Warp Speed funding for its six vaccines has helped them become somewhat dominant leaders in the race for a sizable share of the market.

Shares of Heat Biologics (NASDAQ: HTBX) popped on Thursday after the biopharmaceutical company shared promising preclinical data for its COVID-19 vaccine. As of 1:30 p.m. EDT, Heat Biologics' stock w

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) * Annexon Inc (NASDAQ: ANNX) * Cellular Biomedicine Group Inc (NASDAQ: CBMG) (announced a go-private deal) * Fulgent Genetics Inc (N